Endpoint security

CrowdStrike Positioned as a Leader in 2022 Gartner® Magic Quadrant™ for Endpoint Protection Platforms for Third Consecutive Time

Retrieved on: 
Tuesday, February 28, 2023
Software, Technology, Security, EPP, XDR, Magic Quadrant, DNA, Intelligence, Endpoint detection and response, EDR, Organization, Endpoint security, Research, FAL, Architecture, Publication, Telemetry, Extended detection and response, Medical imaging, Online shopping, Gartner, CrowdStrike

CrowdStrike (Nasdaq: CRWD), a leader in cloud-delivered protection of endpoints, cloud workloads, identity and data, today announced it has been recognized as a Leader in the 2022 Gartner Magic Quadrant for Endpoint Protection Platforms (EPP) for the third consecutive time.

Key Points: 
  • CrowdStrike (Nasdaq: CRWD), a leader in cloud-delivered protection of endpoints, cloud workloads, identity and data, today announced it has been recognized as a Leader in the 2022 Gartner Magic Quadrant for Endpoint Protection Platforms (EPP) for the third consecutive time.
  • Building off a single, lightweight agent architecture, the CrowdStrike Falcon platform now spans endpoint protection, cloud security, identity protection, data protection, managed services, security and IT operations, threat intelligence and observability.
  • CrowdStrike disrupted the endpoint security market by inventing EDR and we believe our placement in the Gartner Magic Quadrant for Endpoint Protection Platforms for a third consecutive time validates our continued dominance in the market.
  • At Fal.Con 2022, CrowdStrike introduced CrowdStrike Falcon Insight XDR, which allows customers to easily expand from EDR to XDR using new XDR connector packs.

Mountain Entities Inc., Licenses Zerify Meet & Zerify Defender to Protect Corporate and Client Data

Retrieved on: 
Tuesday, February 28, 2023
Human, Ecosystem, PHI, EDR, OTC, Data, HIPAA, Zero trust security model, Endpoint security, Forrest Group, Videotelephony, Medical imaging

EDISON, N.J., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Zerify Inc., (OTC PINK: ZRFY), the 21-year-old cybersecurity company focused on securing digital communications announced today that Mountain Entities Inc., has licensed Zerify Meet™ & Zerify Defender™ to protect corporate and client data.

Key Points: 
  • EDISON, N.J., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Zerify Inc., (OTC PINK: ZRFY), the 21-year-old cybersecurity company focused on securing digital communications announced today that Mountain Entities Inc., has licensed Zerify Meet™ & Zerify Defender™ to protect corporate and client data.
  • Since healthcare records are known to be one of the most valuable types of information that hackers are going after, we chose to protect that confidential data with Zerify Meet & Defender.
  • Zerify Defender is the only solution on the market that locks down the camera, microphone, speakers, keyboard, clipboard, and prevents screenscraping.
  • Zerify Meet is the Industry’s only HIPAA certified Video Conferencing platform built on a Zero Trust Architecture.

Versa Networks Earns Multiple Leadership Accolades in KuppingerCole’s SASE Leadership Compass Report for its Industry-Leading SASE Solution

Retrieved on: 
Thursday, February 16, 2023
Mobile, Wireless, Technology, Security, Telecommunications, Software, Networks, Internet, Hardware, Data Management, Artificial Intelligence, Cloud, FW, UTM, Organization, Glass, Data loss prevention software, Next-generation firewall, OS, Zero trust security model, Cloud access security broker, Interoperability, Unified, WAN, SWG, NGFW, RBI, Public sector, Natural language processing, Experience, Joint Service Lightweight Integrated Suit Technology, Customer support, SD, Endpoint security, ATP, DLP, VPN, Browser isolation, Secure access service edge, NLP, Policy, Secure, IAM, ZTNA, Vibration isolation, Research, Spanish Cybersecurity Research Conference, Computer security, Network, CASB, Unified threat management, RFP, Innovation leadership, Usability, Young Innovation Leaders Fellowship, Risk management, Management, Online shopping, SD-WAN

Versa was distinguished as an Overall Leader, Product Leader, Market Leader, and Innovation Leader in KuppingerCole’s report published recently.

Key Points: 
  • Versa was distinguished as an Overall Leader, Product Leader, Market Leader, and Innovation Leader in KuppingerCole’s report published recently.
  • Any organization looking for the full range of SASE features should have Versa on their shortlist for RFP evaluation.
  • KuppingerCole independently evaluated 10 leading SASE providers in its Leadership Compass on SASE Integration Suites report.
  • Versa has a strong Unified SASE product that appeals to most organizations looking for a SASE solution provider.”
    In the Product Leadership category, Versa SASE ranked first on overall product strength and the presence and completeness of required SASE features.

RevBits Endpoint Security Fully and Successfully Deployed, in a government-based entity PoC, for a True Air-Gapped Environment

Retrieved on: 
Monday, February 6, 2023
Public Policy, Government, Software, Networks, White House, Federal Government, Internet, Data Management, Technology, Security, Software as a service, EPS, Artifact, GUI, Air gap, Endpoint security, POC, Federation, LAN, EDR, Computer, USB, Air gap (networking), Registry, Collection, Medical imaging, Phoenix

RevBits announces that it has successfully deployed its endpoint security solution in a true air-gapped environment for a federal government entity.

Key Points: 
  • RevBits announces that it has successfully deployed its endpoint security solution in a true air-gapped environment for a federal government entity.
  • RevBits Endpoint Security (RB/EPS) is a fully featured, robust next-generation endpoint security solution.
  • The solution's EDR module enhances endpoint security and threat mitigation, offering the market the most feature-rich forensics and control capability imaginable.
  • Government entity PoC requirements for an EPS solution in an Air Gapped Environment:
    A recent government-based entity PoC required an EPS solution deployment in a true air-gapped environment.

Bitdefender Recognized Under XDR, EDR and EPP Categories in 2022 Gartner® Hype Cycle™ for Endpoint Security Report

Retrieved on: 
Thursday, January 26, 2023
Technology, Networks, Internet, Security, Organization, Endpoint, MDR, Endpoint detection and response, Gartner hype cycle, XDR, Publication, Epps, Endpoint security, Research, Information security operations center, EDR, EPP, Environment, Medical imaging, Risk management, Cryptocurrency, Bitdefender, Gartner

Bitdefender, a global cybersecurity leader, is pleased to announce that it was recognized in the December 2022 Gartner® Hype Cycle™ for Endpoint Security ¹ report across multiple categories.

Key Points: 
  • Bitdefender, a global cybersecurity leader, is pleased to announce that it was recognized in the December 2022 Gartner® Hype Cycle™ for Endpoint Security ¹ report across multiple categories.
  • The report tracks the innovations that aid security leaders in protecting their enterprise from attacks and breaches.
  • Among the categories tracked by Gartner, Bitdefender was recognized in extended detection and response (XDR), endpoint detection and response (EDR) and endpoint protection platforms (EPP).
  • ¹Gartner, “Hype Cycle for Endpoint Security, 2022”, December 19, 2022.

The Worldwide Managed Detection and Response Industry is Expected to Reach $8.67 Billion by 2030: Increased Application of MDR Solutions in the BFSI Sector Drives Growth

Retrieved on: 
Tuesday, February 14, 2023
Cloud, Retail, Telecom, Security, Organization, MDR, Cloud computing security, Government, Deployment, Geography, Endpoint security, Small and medium-sized enterprises, Small, ETI Telecom, Small and Medium Enterprise Administration, Health care, BFSI, Network security, Medical device, Speciality chemicals

Global Managed Detection and Response (MDR) Market, by Security, 2018 - 2030 (USD Billion)

Key Points: 
  • Global Managed Detection and Response (MDR) Market, by Security, 2018 - 2030 (USD Billion)
    5.3.1.
  • Global Managed Detection and Response (MDR) Market, by Endpoint Security, by Region, 2018 - 2030 (USD Billion)
    5.4.1.
  • Global Managed Detection and Response (MDR) Market, by Network Security, by Region, 2018 - 2030 (USD Billion)
    5.5.1.
  • Global Managed Detection and Response (MDR) Market, by Cloud Security, by Region, 2018 - 2030 (USD Billion)
    6.

United Kingdom Cyber Security Market Report 2023-2027 Featuring Broadcom, IBM, Palo Alto Networks, Mcafee, Cisco, Dell, Fortinet, BAE Systems, Check Point Software Technologies, & Trend Micro

Retrieved on: 
Saturday, February 11, 2023
Cloud, Organization, Government, Internet of things, Investment, Data wrangling, Cloud computing security, Content, Security type system, Artificial intelligence, Endpoint security, Network, Risk, Application, Internet, Growth, Machine learning, Application security, Cyberattack, Cryptocurrency, Online shopping, Arms industry

With the need to protect confidential data from unauthorized access, organizations are actively adopting cybersecurity solutions.

Key Points: 
  • With the need to protect confidential data from unauthorized access, organizations are actively adopting cybersecurity solutions.
  • Increased focus on developing advanced cybersecurity solutions and favorable government policies is expected to propel the United Kingdom's cyber security market in the next five years.
  • The increased need to secure information by organizations is expected to bolster the demand for the United Kingdom cybersecurity market over the next five years.
  • Company Profiles: Detailed analysis of the major companies present in the United Kingdom cyber security market.

Galapagos presented encouraging initial safety and efficacy data at 2023 EBMT-EHA for point-of-care manufactured CAR-T candidate, GLPG5201, in rrCLL

Retrieved on: 
Thursday, February 9, 2023
CET, Galapagos NV, Cytokine release syndrome, Safety, PD, Infrared spectroscopy correlation table, RT, EBMT, Blood, Euronext, Endpoint security, CR, Toxic shock syndrome, CAR, Patient, ORR, CRS, CD19, Lymphatic system, EHA, DL2, European Society for Medical Oncology, Acceleration, Vaccine, Pharmaceutical industry

All patients received GLPG5201 as a fresh infusion with a median vein-to-vein time of 7 days.

Key Points: 
  • All patients received GLPG5201 as a fresh infusion with a median vein-to-vein time of 7 days.
  • Moreover, the initial efficacy results are encouraging with an objective response rate (ORR) of 100% observed.
  • In the safety analysis of these 7 patients, adverse events were consistent with the known toxicities of CD19 CAR-T treatment.
  • “We were very pleased to present strong initial data from the ongoing Phase 1/2 study of our fresh CD19 CAR-T candidate manufactured at point-of-care.

Mesoblast Resubmits Biologic License Application (BLA) to FDA for Remestemcel-L in Children With Steroid-Refractory Acute Graft Versus Host Disease (Sr-aGVHD)

Retrieved on: 
Tuesday, January 31, 2023
Survival, Food, Safety, File, MSB, Inflammation, IND, Mortality, Biomarker, CRL, Endpoint security, BLA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, FDA, Lymphatic system, First, MESO, SR, Priority review, Pharmaceutical industry, Mesoblast

If remestemcel-L receives FDA approval, it will be the first allogeneic “off-the-shelf” cellular medicine to be approved in the United States, and the first therapy for children under 12 years old with SR-aGVHD.

Key Points: 
  • If remestemcel-L receives FDA approval, it will be the first allogeneic “off-the-shelf” cellular medicine to be approved in the United States, and the first therapy for children under 12 years old with SR-aGVHD.
  • The BLA resubmission will have a review period up to six months from filing upon acceptance by FDA.
  • “There is an urgent need for a therapy that improves the dismal survival outcome in children with SR-aGVHD” said Dr. Silviu Itescu, Chief Executive of Mesoblast.
  • “Our team has worked tirelessly over the past two years to provide a comprehensive response to the FDA.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spectrum Pharmaceuticals, Inc. of Class Acton Lawsuit and Upcoming Deadline – SPPI

Retrieved on: 
Sunday, January 29, 2023
Steps, Lebel, Complaint, Diagnosis, Safety, HER2, Failure, Reuters, Pomerantz, Cancer, CRL, LLP, Endpoint security, ODAC, NSCLC, Risk, Court, Survival, NDA, BID, Spectrum Pharmaceuticals, Patient, SPPI, Person, FDA, Ext, Jefferies, District court, AA, Neoplasm, News, Private investigator, Pharmaceutical industry, Medical device, Spectrum, Defendant

Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Key Points: 
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Spectrum purports to be a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology therapies.
  • The complaint alleges that, before the Class Period, Defendants were conducting a Phase 2 clinical trial called ZENITH20.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.